Protagonist Therapeutics (PTGX) Enterprise Value: 7.553B

Protagonist Therapeutics, Inc. (PTGX)

134.58 +5.83 (+4.53%) USD | NASDAQ | Oct 19, 16:00

134.58 0.00 (0.00%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2016. Start Trial.

Date	Value
October 16, 2026	7.553B
October 15, 2026	8.058B
October 14, 2026	8.040B
October 13, 2026	8.183B
October 12, 2026	8.596B
October 09, 2026	8.522B
October 08, 2026	8.275B
October 07, 2026	8.340B
October 06, 2026	8.196B
October 05, 2026	8.321B
October 02, 2026	8.285B
October 01, 2026	8.228B
September 30, 2026	8.338B
September 29, 2026	8.343B
September 28, 2026	8.439B
September 25, 2026	8.401B
September 24, 2026	8.109B
September 23, 2026	8.197B
September 22, 2026	8.609B
September 21, 2026	8.603B
September 18, 2026	8.475B
September 17, 2026	8.520B
September 16, 2026	8.464B
September 15, 2026	8.501B
September 14, 2026	8.784B

Date	Value
September 11, 2026	8.810B
September 10, 2026	8.614B
September 09, 2026	8.610B
September 08, 2026	8.665B
September 04, 2026	8.651B
September 03, 2026	8.850B
September 02, 2026	8.674B
September 01, 2026	8.700B
August 31, 2026	8.782B
August 28, 2026	8.561B
August 27, 2026	8.895B
August 26, 2026	9.024B
August 25, 2026	8.966B
August 24, 2026	9.233B
August 21, 2026	9.207B
August 20, 2026	8.972B
August 19, 2026	9.247B
August 18, 2026	9.402B
August 17, 2026	9.485B
August 14, 2026	9.257B
August 13, 2026	9.019B
August 12, 2026	9.057B
August 11, 2026	8.817B
August 10, 2026	8.927B
August 07, 2026	8.660B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks